- Corporate Officers - G
- Gsk Plc
Insider Trading History of Gsk Plc
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Gsk Plc since 2009.
This trader's CIK number is 1131399.
At the time of last reporting, Gsk Plc was the Officer of Wave Life Sciences Ltd.. (stock ticker symbol WVE).
Also see all insider trading activities at Wave Life Sciences Ltd..
Note that in the past
GSK plc also reported insider trading activities as an insider of the following companies:
Insider Activities at Wave Life Sciences Ltd. (WVE)
Insider Activities at Cvrx, Inc. (CVRX)
Insider Activities at Innoviva, Inc. (INVA)
Insider Activities at Decibel Therapeutics, Inc. (DBTX)
Insider Activities at Bicycle Therapeutics Plc (BCYC)
Insider Activities at Genocea Biosciences, Inc. (GNCA)
Insider Activities at Pandion Therapeutics, Inc. (PAND)
Insider Activities at Nkarta, Inc. (NKTX)
Insider Activities at Turning Point Therapeutics, Inc. (TPTX)
Insider Activities at Progyny, Inc. (PGNY)
Insider Activities at Principia Biopharma Inc. (PRNB)
Insider Activities at Morphic Holding, Inc. (MORF)
Insider Activities at Chemocentryx, Inc. (CCXI)
Insider Activities at Liquidia Technologies Inc (LQDA)
Insider Activities at Spero Therapeutics, Inc. (SPRO)
Insider Activities at Translate Bio, Inc. (TBIO)
Insider Activities at Htg Molecular Diagnostics, Inc (HTGM)
Insider Activities at Crispr Therapeutics Ag (CRSP)
Insider Activities at Theravance Biopharma, Inc. (TBPH)
Insider Activities at Applied Genetic Technologies Corp (AGTC)
Insider Activities at Amicus Therapeutics, Inc. (FOLD)
Insider Activities at Concert Pharmaceuticals, Inc. (CNCE)
Insider Activities at Human Genome Sciences Inc (HGSI)
Insider Activities at Quest Diagnostics Inc (DGX)
Insider Activities at Anacor Pharmaceuticals Inc (ANAC)
Yearly summary of insider trading at Quest Diagnostics Inc (DGX) by Gsk Plc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2011 | DGX | 0 | $0 | 30,755,151 | $1,690,241,588 | 0 | $0 |
2009 | DGX | 0 | $0 | 5,749,157 | $257,784,615 | 0 | $0 |
Yearly summary of insider trading at Theravance Biopharma, Inc. (TBPH) by Gsk Plc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2016 | TBPH | 1,301,015 | $29,959,728,534,982 | 0 | $0 | 0 | $0 |
2015 | TBPH | 44,574 | $27,080,649,317 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Translate Bio, Inc. (TBIO) by Gsk Plc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2018 | TBIO | 269,230 | $3,499,990 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Crispr Therapeutics Ag (CRSP) by Gsk Plc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2016 | CRSP | 66,500 | $931,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Wave Life Sciences Ltd. (WVE) by Gsk Plc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2024 | WVE | 6,091,930 | $38,835,440 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Htg Molecular Diagnostics, Inc (HTGM) by Gsk Plc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2017 | HTGM | 0 | $0 | 300,000 | $3,045,300 | 0 | $0 |
2015 | HTGM | 365,106 | $5,111,484 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Nkarta, Inc. (NKTX) by Gsk Plc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2020 | NKTX | 833,333 | $14,999,994 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Innoviva, Inc. (INVA) by Gsk Plc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2021 | INVA | 0 | $0 | 32,005,260 | $392,064,435 | 0 | $0 |
2015 | INVA | 424,081 | $1,129,205,348,221 | 0 | $0 | 0 | $0 |
2014 | INVA | 1,665,106 | $18,432,850,534,746 | 0 | $0 | 0 | $0 |
2013 | INVA | 3,504,970 | $344,993,493,913,188 | 0 | $0 | 0 | $0 |
2012 | INVA | 10,685,150 | $1,756,821,691,496 | 0 | $0 | 0 | $0 |
2011 | INVA | 471,988 | $11,596,718 | 0 | $0 | 0 | $0 |
2010 | INVA | 5,750,000 | $129,375,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Liquidia Technologies Inc (LQDA) by Gsk Plc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2018 | LQDA | 148,818 | $1,636,998 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Applied Genetic Technologies Corp (AGTC) by Gsk Plc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2015 | AGTC | 0 | $0 | 553,150 | $12,127,023 | 0 | $0 |
2014 | AGTC | 103,762 | $1,245,144 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Cvrx, Inc. (CVRX) by Gsk Plc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2021 | CVRX | 275,000 | $4,950,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Chemocentryx, Inc. (CCXI) by Gsk Plc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2018 | CCXI | 0 | $0 | 7,343,492 | $85,845,421 | 0 | $0 |
Yearly summary of insider trading at Human Genome Sciences Inc (HGSI) by Gsk Plc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2012 | HGSI | 75,055,830 | $1,069,545,575 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Progyny, Inc. (PGNY) by Gsk Plc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2020 | PGNY | 0 | $0 | 4,000,000 | $103,000,000 | 0 | $0 |
Yearly summary of insider trading at Genocea Biosciences, Inc. (GNCA) by Gsk Plc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2020 | GNCA | 1,260,504 | $2,836,134 | 0 | $0 | 0 | $0 |
2019 | GNCA | 1,857,142 | $6,499,997 | 0 | $0 | 0 | $0 |
2014 | GNCA | 143,773 | $1,725,276 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Anacor Pharmaceuticals Inc (ANAC) by Gsk Plc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2010 | ANAC | 1,000,000 | $5,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Bicycle Therapeutics Plc (BCYC) by Gsk Plc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2020 | BCYC | 0 | $0 | 4,744 | $91,598 | 0 | $0 |
2019 | BCYC | 385,714 | $5,399,996 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Amicus Therapeutics, Inc. (FOLD) by Gsk Plc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2014 | FOLD | 0 | $0 | 11,315,825 | $59,872,030 | 0 | $0 |
2013 | FOLD | 1,500,000 | $3,000,000 | 0 | $0 | 0 | $0 |
2012 | FOLD | 2,949,581 | $18,582,360 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Pandion Therapeutics, Inc. (PAND) by Gsk Plc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2020 | PAND | 361,111 | $6,499,998 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Decibel Therapeutics, Inc. (DBTX) by Gsk Plc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2021 | DBTX | 150,000 | $2,700,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Morphic Holding, Inc. (MORF) by Gsk Plc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | MORF | 333,333 | $4,999,995 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Turning Point Therapeutics, Inc. (TPTX) by Gsk Plc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2020 | TPTX | 83,333 | $4,999,980 | 0 | $0 | 0 | $0 |
2019 | TPTX | 502,777 | $13,849,965 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Concert Pharmaceuticals, Inc. (CNCE) by Gsk Plc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2014 | CNCE | 35,000 | $490,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Spero Therapeutics, Inc. (SPRO) by Gsk Plc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2018 | SPRO | 80,000 | $1,000,000 | 0 | $0 | 0 | $0 |
2017 | SPRO | 428,571 | $5,999,994 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Principia Biopharma Inc. (PRNB) by Gsk Plc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | PRNB | 357,142 | $9,999,976 | 0 | $0 | 0 | $0 |
2018 | PRNB | 270,000 | $4,590,000 | 0 | $0 | 0 | $0 |
Insider trading activities at 25 companies by Gsk Plc:
1. Quest Diagnostics Inc (DGX)
2. Theravance Biopharma, Inc. (TBPH)
3. Translate Bio, Inc. (TBIO)
4. Crispr Therapeutics Ag (CRSP)
5. Wave Life Sciences Ltd. (WVE)
6. Htg Molecular Diagnostics, Inc (HTGM)
7. Nkarta, Inc. (NKTX)
8. Innoviva, Inc. (INVA)
9. Liquidia Technologies Inc (LQDA)
10. Applied Genetic Technologies Corp (AGTC)
11. Cvrx, Inc. (CVRX)
12. Chemocentryx, Inc. (CCXI)
13. Human Genome Sciences Inc (HGSI)
14. Progyny, Inc. (PGNY)
15. Genocea Biosciences, Inc. (GNCA)
16. Anacor Pharmaceuticals Inc (ANAC)
17. Bicycle Therapeutics Plc (BCYC)
18. Amicus Therapeutics, Inc. (FOLD)
19. Pandion Therapeutics, Inc. (PAND)
20. Decibel Therapeutics, Inc. (DBTX)
21. Morphic Holding, Inc. (MORF)
22. Turning Point Therapeutics, Inc. (TPTX)
23. Concert Pharmaceuticals, Inc. (CNCE)
24. Spero Therapeutics, Inc. (SPRO)
25. Principia Biopharma Inc. (PRNB)
Table 1. Insider trading of Quest Diagnostics Inc (DGX) by Gsk Plc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2011-01-31 | DGX | Sale | 30,755,151 | 54.96 | 1,690,241,588 |
2009-03-17 | DGX | Sale | 500,000 | 45.50 | 22,749,000 |
2009-03-18 | DGX | Sale | 500,000 | 46.04 | 23,019,000 |
2009-03-19 | DGX | Sale | 4,749,157 | 44.64 | 212,016,615 |
Table 2. Insider trading of Theravance Biopharma, Inc. (TBPH) by Gsk Plc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2016-03-14 | TBPH | Buy | 1,301,015 | 23,027,965.50 | 29,959,728,534,982 |
2015-10-07 | TBPH | Buy | 44,574 | 607,543.62 | 27,080,649,317 |
Table 3. Insider trading of Translate Bio, Inc. (TBIO) by Gsk Plc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2018-07-02 | TBIO | Buy | 269,230 | 13.00 | 3,499,990 |
Table 4. Insider trading of Crispr Therapeutics Ag (CRSP) by Gsk Plc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2016-10-24 | CRSP | Buy | 66,500 | 14.00 | 931,000 |
Table 5. Insider trading of Wave Life Sciences Ltd. (WVE) by Gsk Plc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2024-09-27 | WVE | Buy | 2,791,930 | 8.00 | 22,335,440 |
2023-12-07 | WVE | Buy | 3,300,000 | 5.00 | 16,500,000 |
Table 6. Insider trading of Htg Molecular Diagnostics, Inc (HTGM) by Gsk Plc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2017-03-27 | HTGM | Sale | 300,000 | 10.15 | 3,045,300 |
2015-05-11 | HTGM | Buy | 365,106 | 14.00 | 5,111,484 |
Table 7. Insider trading of Nkarta, Inc. (NKTX) by Gsk Plc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2020-07-14 | NKTX | Buy | 833,333 | 18.00 | 14,999,994 |
Table 8. Insider trading of Innoviva, Inc. (INVA) by Gsk Plc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2021-05-20 | INVA | Sale | 32,005,260 | 12.25 | 392,064,435 |
2015-08-07 | THRX | Buy | 245,828 | 3,485,841.04 | 856,917,331,181 |
2015-05-11 | THRX | Buy | 85,579 | 1,369,264.00 | 117,180,243,856 |
2015-03-02 | THRX | Buy | 92,674 | 1,673,692.44 | 155,107,773,184 |
2014-11-04 | THRX | Buy | 832,456 | 12,786,524.16 | 10,644,218,756,136 |
2014-08-11 | THRX | Buy | 172,651 | 3,912,271.66 | 675,457,614,370 |
2014-05-09 | THRX | Buy | 317,770 | 8,544,835.30 | 2,715,292,313,281 |
2014-02-11 | THRX | Buy | 342,229 | 12,850,698.95 | 4,397,881,850,959 |
2013-10-29 | THRX | Buy | 130,473 | 4,913,613.18 | 641,093,852,434 |
2013-07-30 | THRX | Buy | 3,064,407 | 111,850,855.50 | 342,756,544,550,188 |
2013-04-30 | THRX | Buy | 193,563 | 6,699,215.43 | 1,296,720,236,277 |
2013-02-15 | THRX | Buy | 116,527 | 2,567,089.81 | 299,135,274,289 |
2012-11-02 | THRX | Buy | 280,348 | 6,265,777.80 | 1,756,598,274,674 |
2012-08-03 | THRX | Buy | 316,334 | 28.21 | 8,923,782 |
2012-05-16 | THRX | Buy | 10,000,000 | 21.29 | 212,890,000 |
2012-02-14 | THRX | Buy | 88,468 | 18.12 | 1,603,040 |
2011-11-01 | THRX | Buy | 58,411 | 22.23 | 1,298,476 |
2011-05-03 | THRX | Buy | 261,299 | 25.60 | 6,689,254 |
2011-02-18 | THRX | Buy | 152,278 | 23.70 | 3,608,988 |
2010-11-29 | THRX | Buy | 5,750,000 | 22.50 | 129,375,000 |
Table 9. Insider trading of Liquidia Technologies Inc (LQDA) by Gsk Plc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2018-07-30 | LQDA | Buy | 148,818 | 11.00 | 1,636,998 |
Table 10. Insider trading of Applied Genetic Technologies Corp (AGTC) by Gsk Plc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2015-02-23 | AGTC | Sale | 503,150 | 22.00 | 11,069,803 |
2014-12-18 | AGTC | Sale | 12,000 | 21.01 | 252,132 |
2014-12-10 | AGTC | Sale | 10,000 | 21.18 | 211,759 |
2014-12-11 | AGTC | Sale | 12,500 | 21.28 | 266,037 |
2014-12-12 | AGTC | Sale | 7,500 | 21.24 | 159,292 |
2014-12-17 | AGTC | Sale | 8,000 | 21.00 | 168,000 |
2014-04-01 | AGTC | Buy | 103,762 | 12.00 | 1,245,144 |
Table 11. Insider trading of Cvrx, Inc. (CVRX) by Gsk Plc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2021-07-02 | CVRX | Buy | 275,000 | 18.00 | 4,950,000 |
Table 12. Insider trading of Chemocentryx, Inc. (CCXI) by Gsk Plc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2018-10-16 | CCXI | Sale | 7,343,492 | 11.69 | 85,845,421 |
Table 13. Insider trading of Human Genome Sciences Inc (HGSI) by Gsk Plc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2012-08-01 | HGSI | Buy | 5,686,715 | 14.25 | 81,035,688 |
2012-08-02 | HGSI | Buy | 62,646,186 | 14.25 | 892,708,150 |
2012-08-01 | HGSI | Buy | 1,788,186 | 14.25 | 25,481,650 |
2012-07-30 | HGSI | Buy | 4,934,743 | 14.25 | 70,320,087 |
Table 14. Insider trading of Progyny, Inc. (PGNY) by Gsk Plc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2020-05-20 | PGNY | Sale | 4,000,000 | 25.75 | 103,000,000 |
Table 15. Insider trading of Genocea Biosciences, Inc. (GNCA) by Gsk Plc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2020-07-24 | GNCA | Buy | 1,260,504 | 2.25 | 2,836,134 |
2019-06-24 | GNCA | Buy | 1,857,142 | 3.50 | 6,499,997 |
2014-02-10 | GNCA | Buy | 143,773 | 12.00 | 1,725,276 |
Table 16. Insider trading of Anacor Pharmaceuticals Inc (ANAC) by Gsk Plc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2010-11-24 | ANAC | Buy | 1,000,000 | 5.00 | 5,000,000 |
Table 17. Insider trading of Bicycle Therapeutics Plc (BCYC) by Gsk Plc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2020-07-14 | BCYC | Sale | 1,597 | 19.27 | 30,780 |
2020-07-15 | BCYC | Sale | 3,147 | 19.33 | 60,818 |
2019-05-28 | BCYC | Buy | 385,714 | 14.00 | 5,399,996 |
Table 18. Insider trading of Amicus Therapeutics, Inc. (FOLD) by Gsk Plc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2014-10-27 | FOLD | Sale | 11,315,825 | 5.29 | 59,872,030 |
2013-11-20 | FOLD | Buy | 1,500,000 | 2.00 | 3,000,000 |
2012-07-17 | FOLD | Buy | 2,949,581 | 6.30 | 18,582,360 |
Table 19. Insider trading of Pandion Therapeutics, Inc. (PAND) by Gsk Plc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2020-07-21 | PAND | Buy | 361,111 | 18.00 | 6,499,998 |
Table 20. Insider trading of Decibel Therapeutics, Inc. (DBTX) by Gsk Plc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2021-02-17 | DBTX | Buy | 150,000 | 18.00 | 2,700,000 |
Table 21. Insider trading of Morphic Holding, Inc. (MORF) by Gsk Plc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-07-01 | MORF | Buy | 333,333 | 15.00 | 4,999,995 |
Table 22. Insider trading of Turning Point Therapeutics, Inc. (TPTX) by Gsk Plc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2020-05-21 | TPTX | Buy | 83,333 | 60.00 | 4,999,980 |
2019-09-10 | TPTX | Buy | 177,777 | 45.00 | 7,999,965 |
2019-04-22 | TPTX | Buy | 325,000 | 18.00 | 5,850,000 |
Table 23. Insider trading of Concert Pharmaceuticals, Inc. (CNCE) by Gsk Plc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2014-02-19 | CNCE | Buy | 35,000 | 14.00 | 490,000 |
Table 24. Insider trading of Spero Therapeutics, Inc. (SPRO) by Gsk Plc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2018-07-17 | SPRO | Buy | 80,000 | 12.50 | 1,000,000 |
2017-11-06 | SPRO | Buy | 428,571 | 14.00 | 5,999,994 |
Table 25. Insider trading of Principia Biopharma Inc. (PRNB) by Gsk Plc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-10-18 | PRNB | Buy | 357,142 | 28.00 | 9,999,976 |
2018-09-18 | PRNB | Buy | 270,000 | 17.00 | 4,590,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Gsk Plc
(Officer of Wave Life Sciences Ltd. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.